Here’s what you need to know:
1. The grant was awarded to Subhash Chauhan, PhD, a professor at the University of Tennessee Health Science Center’s department of pharmaceutical sciences.
2. Dr. Chauhan’s research focuses on the identification of biomarkers that influence colorectal cancer development.
3. The $1.75 million grant will be dispensed over the course of five years.
More articles on gastroenterology and endoscopy:
Global market for gastrointestinal drugs to reach $48.4B by 2022: 5 notes
Cologuard included in 2017 HEDIS quality measures for CRC screening: 4 notes
Smoking heightens risk of Crohn’s relapse after intestinal resection: 3 study insights
